Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 10/20 | 0.47 |
| ▸ | CA2 | P00918 | 10/20 | 0.47 |
| ▸ | CA9 | Q16790 | 8/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.47 |
| ▸ | CA7 | P43166 | 3/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.47 |
| ▸ | CA3 | P07451 | 2/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA6 | P23280 | 2/20 | 0.47 |
| ▸ | CA5A | P35218 | 2/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trolamine SCHEMBL97773 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| Trolamine SCHEMBL378933 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| Trolamine SCHEMBL9481005 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| Trolamine SCHEMBL10612409 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| Trolamine SCHEMBL430868 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| Trolamine SCHEMBL2323494 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| Trolamine SCHEMBL10948957 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| Octadecyl Sulfate SCHEMBL3963772 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| Trolamine SCHEMBL3656221 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| Trolamine SCHEMBL10888113 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4210492-B1 | DISSOLVABLE SOLID ARTICLE CONTAINING ANTI-BACTERIAL ACTIVES | PROCTER & GAMBLE (US) | 2026-04-01 | — | — | EP | disclosed |
| US-12364651-B2 | Flexible, porous, dissolvable solid sheet article containing direct-added microcapsules and process for making the same | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-22 | — | — | US | disclosed |
| US-12343423-B2 | Dissolvable solid article containing preservatives | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-01 | — | — | US | disclosed |
| US-12129451-B2 | Dissolvable solid article containing silicone | THE PROCTER & GAMBLE COMPANY (US) | 2024-10-29 | — | — | US | disclosed |
| EP-4387579-A1 | DISSOLVABLE SOLID ARTICLE CONTAINING SILICONE | The Procter & Gamble Company (US) | 2024-06-26 | — | — | EP | disclosed |
| CN-117835951-A | Soluble solid articles containing silicone | 宝洁公司 | 2024-04-05 | — | — | CN | disclosed |
| EP-4281029-A1 | DISSOLVABLE SOLID ARTICLE CONTAINING PRESERVATIVES | The Procter & Gamble Company (US) | 2023-11-29 | — | — | EP | disclosed |
| US-11826439-B2 | Dissolvable solid article containing anti-bacterial actives | THE PROCTER & GAMBLE COMPANY (US) | 2023-11-28 | — | — | US | disclosed |
| US-20230332075-A1 | DISSOLVABLE SOLID ARTICLE CONTAINING SILICONE | THE PROCTER & GAMBLE COMPANY | 2023-10-19 | — | — | US | disclosed |
| CN-116761578-A | Soluble solid articles containing preservative | 宝洁公司 | 2023-09-15 | — | — | CN | disclosed |
| EP-2355773-B1 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | PROCTER & GAMBLE (US) | 2016-11-09 | — | — | EP | disclosed |
| EP-2355772-B1 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ATRICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | PROCTER & GAMBLE (US) | 2016-11-09 | — | — | EP | disclosed |
| US-8461090-B2 | Personal care composition in the form of an article having a porous, dissolvable solid structure | THE PROCTER & GAMBLE COMPANY (US) | 2013-06-11 | — | — | US | disclosed |
| US-8461091-B2 | Personal care composition in the form of an article having a porous, dissolvable solid structure | THE PROCTER & GAMBLE COMPANY (US) | 2013-06-11 | — | — | US | disclosed |
| EP-2355772-A2 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ATRICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | The Procter & Gamble Company (US) | 2011-08-17 | — | — | EP | disclosed |
| EP-2355773-A2 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | The Procter & Gamble Company (US) | 2011-08-17 | — | — | EP | disclosed |
| US-20100286011-A1 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | THE PROCTER & GAMBLE COMPANY | 2010-11-11 | — | — | US | disclosed |
| US-20100179083-A1 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | THE PROCTER & GAMBLE COMPANY | 2010-07-15 | — | — | US | disclosed |
| WO-2010077628-A2 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ATRICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-08 | — | — | WO | disclosed |
| WO-2010077650-A2 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12364651-B2 | Flexible, porous, dissolvable solid sheet article containing direct-added microcapsules and process for making the same | SLC2A8, SEPTIN8, SLC2A2 | CA1 4176/4885CA2 4351/4885CA9 3778/4885 |
| US-20100286011-A1 | PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE HAVING A POROUS, DISSOLVABLE SOLID STRUCTURE | DSG1, ASH2L, DSC1 | CA1 1448/4885CA2 1243/4885CA9 1021/4885 |
| US-11826439-B2 | Dissolvable solid article containing anti-bacterial actives | DDOST, DDC, DAD1 | CA1 1205/4885CA2 146/4885CA9 403/4885 |
| US-12343423-B2 | Dissolvable solid article containing preservatives | DDC, ACMSD, IDUA | CA1 572/4885CA2 512/4885CA9 1257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.